An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)

Clinical trial NCT00559052 · COMPLETED

Trial details

NCT number: NCT00559052
Sponsor: Axcan Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency

Start date: 2008-03-01
Primary completion: 2009-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.